282 related articles for article (PubMed ID: 25465415)
21. Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases.
Gurzu S; Fetyko A; Bara T; Banias L; Butiurca VO; Bara T; Tudorache V; Jung I
Pathol Res Pract; 2019 Dec; 215(12):152697. PubMed ID: 31704155
[TBL] [Abstract][Full Text] [Related]
22. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
23. Microsatellite instability in gallbladder carcinoma.
Moy AP; Shahid M; Ferrone CR; Borger DR; Zhu AX; Ting D; Deshpande V
Virchows Arch; 2015 Apr; 466(4):393-402. PubMed ID: 25680569
[TBL] [Abstract][Full Text] [Related]
24. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma.
Bao F; Panarelli NC; Rennert H; Sherr DL; Yantiss RK
Am J Surg Pathol; 2010 Dec; 34(12):1798-804. PubMed ID: 21107085
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.
Sugimoto R; Sugai T; Habano W; Endoh M; Eizuka M; Yamamoto E; Uesugi N; Ishida K; Kawasaki T; Matsumoto T; Suzuki H
Int J Cancer; 2016 Apr; 138(7):1689-97. PubMed ID: 26538087
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic and molecular profiles of microsatellite unstable Barrett Esophagus-associated adenocarcinoma.
Farris AB; Demicco EG; Le LP; Finberg KE; Miller J; Mandal R; Fukuoka J; Cohen C; Gaissert HA; Zukerberg LR; Lauwers GY; Iafrate AJ; Mino-Kenudson M
Am J Surg Pathol; 2011 May; 35(5):647-55. PubMed ID: 21422910
[TBL] [Abstract][Full Text] [Related]
28. High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin.
Litmeyer AS; Konukiewitz B; Kasajima A; Foersch S; Schicktanz F; Schmitt M; Kellers F; Grass A; Jank P; Lehman B; Gress TM; Rinke A; Bartsch DK; Denkert C; Weichert W; Klöppel G; Jesinghaus M
J Pathol Clin Res; 2023 Nov; 9(6):498-509. PubMed ID: 37608427
[TBL] [Abstract][Full Text] [Related]
29. KRAS signaling pathway alterations in microsatellite unstable gastrointestinal cancers.
Velho S; Corso G; Oliveíra C; Seruca R
Adv Cancer Res; 2010; 109():123-43. PubMed ID: 21070916
[TBL] [Abstract][Full Text] [Related]
30. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas.
Jesinghaus M; Konukiewitz B; Keller G; Kloor M; Steiger K; Reiche M; Penzel R; Endris V; Arsenic R; Hermann G; Stenzinger A; Weichert W; Pfarr N; Klöppel G
Mod Pathol; 2017 Apr; 30(4):610-619. PubMed ID: 28059096
[TBL] [Abstract][Full Text] [Related]
31. Gastric mixed adenoneuroendocrine carcinoma: correlation of histologic characteristics with prognosis.
Nie L; Li M; He X; Feng A; Wu H; Fan X
Ann Diagn Pathol; 2016 Dec; 25():48-53. PubMed ID: 27806846
[TBL] [Abstract][Full Text] [Related]
32. Clinical implications of mismatch repair deficiency screening in patients with mixed neuroendocrine non-neuroendocrine neoplasms (MiNEN).
Lou L; Lv F; Wu X; Li Y; Zhang X
Eur J Surg Oncol; 2021 Feb; 47(2):323-330. PubMed ID: 32907775
[TBL] [Abstract][Full Text] [Related]
33. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.
Walter T; Tougeron D; Baudin E; Le Malicot K; Lecomte T; Malka D; Hentic O; Manfredi S; Bonnet I; Guimbaud R; Coriat R; Lepère C; Desauw C; Thirot-Bidault A; Dahan L; Roquin G; Aparicio T; Legoux JL; Lombard-Bohas C; Scoazec JY; Lepage C; Cadiot G;
Eur J Cancer; 2017 Jul; 79():158-165. PubMed ID: 28501762
[TBL] [Abstract][Full Text] [Related]
34. Alterations in ERBB2 and BRCA and microsatellite instability as new personalized treatment options in small bowel carcinoma.
Quaas A; Heydt C; Waldschmidt D; Alakus H; Zander T; Goeser T; Kasper P; Bruns C; Brunn A; Roth W; Hartmann N; Bunck A; Schmidt M; Buettner R; Merkelbach-Bruse S
BMC Gastroenterol; 2019 Feb; 19(1):21. PubMed ID: 30717682
[TBL] [Abstract][Full Text] [Related]
35. Comparative Outcomes in Patients With Small- and Large-Cell Neuroendocrine Carcinoma (NEC) and Mixed Neuroendocrine-Non-Neuroendocrine Neoplasm (MiNEN) of the Stomach.
Choi NY; Kim BS; Oh ST; Yook JH; Kim BS
Am Surg; 2021 Apr; 87(4):631-637. PubMed ID: 33142079
[TBL] [Abstract][Full Text] [Related]
36. Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.
Ali AS; Grönberg M; Federspiel B; Scoazec JY; Hjortland GO; Grønbæk H; Ladekarl M; Langer SW; Welin S; Vestermark LW; Arola J; Österlund P; Knigge U; Sorbye H; Grimelius L; Janson ET
PLoS One; 2017; 12(11):e0187667. PubMed ID: 29112960
[TBL] [Abstract][Full Text] [Related]
37. Molecular Characterization of Neuroendocrine Carcinomas of the Endometrium: Representation in All 4 TCGA Groups.
Howitt BE; Dong F; Vivero M; Shah V; Lindeman N; Schoolmeester JK; Baltay M; MacConaill L; Sholl LM; Nucci MR; McCluggage WG
Am J Surg Pathol; 2020 Nov; 44(11):1541-1548. PubMed ID: 32773531
[TBL] [Abstract][Full Text] [Related]
38. Microsatellite instability in pediatric high grade glioma is associated with genomic profile and differential target gene inactivation.
Viana-Pereira M; Lee A; Popov S; Bax DA; Al-Sarraj S; Bridges LR; Stávale JN; Hargrave D; Jones C; Reis RM
PLoS One; 2011; 6(5):e20588. PubMed ID: 21637783
[TBL] [Abstract][Full Text] [Related]
39. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic Characteristics of Microsatellite Instable Gastric Carcinomas Revisited: Urgent Need for Standardization.
Mathiak M; Warneke VS; Behrens HM; Haag J; Böger C; Krüger S; Röcken C
Appl Immunohistochem Mol Morphol; 2017 Jan; 25(1):12-24. PubMed ID: 26371427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]